Evli Growth Partners

  • DATABASE (365)

  • ARTICLES (542)

    • DATABASE (365)
    • ARTICLES (542)
  • Sort by
    • Relevance
    • Date

Founded in 1993, as part of the Consortium of Vigo Free Trade Zone, the firm invests in startups from the Spanish autonomous region of Galicia throughout the seed, growth and acquisition stages. Vigo normally takes minority stakes of 5–40%. It also provides loans and participates in leveraged acquisitions, including management buy-outs, buy-ins or a mixture of both.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. It has invested in 50 companies and manages RMB2bn worth of total assets. Bioventure invests mostly in the life sciences and bio-pharmaceutical industries, seeking early-stage startups with high growth potential. Bioventure provides post-investment support and services including funding, business operations and management.

Founded in 2018, Linden Asset Group currently has offices in Nanjing, Shenzhen and Singapore. With both US dollar- and RMB-denominated funds under management, it is focused on the fields of biotechnology, medtech and smart technology in the Asia Pacific region. Linden Asset prefers growth-stage startups that are cutting-edge in their respective areas and plans for overseas expansion.

Established in 2010, Flourish Libra Venture Capital is a Fund of Funds (FOF) management firm and focuses on private equity in Greater China. It has invested some funds under Jiuding Capital, Fortune, NewMargin Ventures, Tiantu Capital, SAIF Partners, etc.

San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods. 

Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.

As part of Vertex Ventures Holdings, a member of Temasek Holdings and Singapore's oldest and largest venture capital firm, Vertex Ventures China focuses on investment in high-growth internet and technology startups across mainland China. Vertex Ventures Holdings has a capital of US$600 million. It also has offices in Singapore, the US and Israel; and investments in these regions as well as Asia.

Co-Stone is one of the earliest venture capital firms in China, with about RMB 30 billion in assets under management today. It operates growth-stage investments and pre-IPO financings, focusing on TMT, biotechnology, consumer and services sectors in China. It has invested in more than 80 companies, where Co-Stone was the lead investor in over 60% of the financings.

Rentracks is an adtech company from Japan, listed in the “Mothers” (Market of the High-Growth and Emerging Stocks) board of the Tokyo Stock Exchange. The company provides consultancy services for web development (for SEO, SEM, and other ad purposes) and Internet-based ads. Rentracks also has a network of affiliate companies in various Asian countries, including China, India, Indonesia, and the Philippines.

The Woodford Patient Capital Trust is part of the larger group Woodford Funds. The company is based in Oxford and was formed in 2014, headed by veteran fund manager Neil Woodford. The Patient Capital Trust focuses on early- and early-growth-stage companies, with target returns of more than 10% yearly. The bulk of their portfolio comprises healthcare companies. 

The Stanford Management Company (SMC) invests through the Merged Pool that oversees the majority of its investable assets. Its portfolio includes diverse equity-oriented strategies: domestic and foreign public equities (27%), real estate (8%), natural resources (7%) and private equity (30%). Private equity is maintained at 30% of the Merged Pool based on its risk-return criteria. The Merged Pool was valued at $29.6 bn as of June 30, 2019.The private equity division operates through selected external partners for early and later-stage investments. According to the university’s latest investment report, the SMC is working to improve its investment portfolio that has become over diversified during the last four years, making it difficult to maintain quality and drive superior returns. The number of active partners has been reduced to 75 including 37 new ones added in the last four years. The new partners have generated a net internal rate of return of 29.3% over the last four years.

The Graduate Syndicate is led by Harvard Business School senior lecturer Jeff Bussgang. The fund primarily invests in startups founded by Harvard graduates, particularly HBS alumni. It is linked to Flybridge Capital Partners, where Jeff Bussgang has served as a general partner since 2003.

Christopher Angkasa is an angel investor. He is a managing partner at angel investing firm Denali Partners and a co-founder of wealth consultancy firm Akara Capital. He also founded Clapham Collective, a coworking space in Medan that is now part of EV Hive.

Based in Shanghai, BA Capital focuses on investments in various consumer sectors. The VC, a subsidiary of Black Ant Group in Shenzhen, was founded in 2016 by three partners Chen Feng, He Yu and Zhang Peiyuan

Founded at the end of 2019, Youshan Capital has raised RMB 3.3bn for its first fund, landing FOF, listed companies, state-owned companies and government guidance funds as its limited partners. It mainly invests in the sectors including TMT, medtech and advanced manufacturing. 

Sorry, we couldn’t find any matches for“Evli Growth Partners”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.